Skip to main content
. 2017 Jun 29;9(7):203. doi: 10.3390/toxins9070203

Table 3.

Method performances in urine and serum.

LoQ a, ng/mL RA b, % SSE c, % RE d, % RSDr e, % LoQ, ng/mL RA, % SSE, % RE, % RSDr, %
Compound Urine Serum
GLIO f 1.1 97 86 112 22 11 63 104 61 15
OTA g 0.16 69 76 90 17 0.16 56 79 71 21
AFB1 h 0.03 103 111 93 23 0.01 82 92 89 22
AFM1 i 0.32 70 71 99 18 0.22 52 72 73 19
ZEA j 1.6 78 82 95 19 1.0 50 87 57 19
DON k 1.4 66 73 90 10 5.0 59 62 97 13
DOM1 l 5.0 67 58 115 23 5.0 60 54 111 14
FB1 m 1.1 72 64 112 10 3.0 56 85 66 23

a Limit of Quantification; b Apparent recovery; c Signal Suppression/Enhancement; d Recovery for extraction; e Relative Standard Deviation (repeatability); f Gliotoxin; g Ochratoxin A; h Aflatoxin B1; i Aflatoxin M1; j Zearalenone; k Deoxynivalenol; l De-epoxy deoxynivalenol-1; m Fumonisin B1.